Arcutis Nears FDA Decision On Roflumilast Cream For Atopic Dermatitis
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Arcutis Biotherapeutics Inc. (ARQT), an early commercial-stage biopharmaceutical company specializing in immuno-dermatology, has a significant regulatory catalyst approaching.
:max_bytes(150000):strip_icc():format(jpeg)/401krollovernewemployee-64d3875ffb264417a9979cdab5a5fc7d-eb7f7d1e1b93420ebb3d5fe68671a752.jpg "Should You Roll Over an Old 401(k) to a New 401(k)?")
:max_bytes(150000):strip_icc():format(jpeg)/income-tax-4097292_1920-bcff7b73c783425889ad73d26a02b33a.jpg "The Tax Advantages of MLPs")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1794651796-b589aa742af949618d90fdaeaa3924da.jpg "Hedging in the Forex Market: Definition and Strategies")
:max_bytes(150000):strip_icc():format(jpeg)/NewsImages-PackageonWhatToExpect3-final-04daeaf95d3a4dc7972aa4591eb982a6.png "<div>Can AI Enthusiasm Sustain the Magnificent 7's Momentum?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1365692265-f3539aa628e34343b5309da9b4a203d2.jpg "How Mutual Funds Pay Dividends")